Search
Risedronic acid
go.drugbank.com/drugs/DB00884ApprovedInvestigationalRisedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111].
Mixtures: RISEPLUS TEDAVI PAKETİ, 4+24 ADET, RISEFIX COMBI TEDAVI PAKETI, 4+24 ADETCategories: Heterocyclic Compounds, 1-RingAluminum zirconium tetrachlorohydrex gly
go.drugbank.com/drugs/DB11149ApprovedWithdrawnAluminum zirconium tetrachlorohydrex gly is a common active ingredient in personal care products as an antiperspirant agent.
Products: Big V Stk A/p Scented 22%, Big V Ladies Stk A/p 23% Pwr ScentPhenolphthalein
go.drugbank.com/drugs/DB04824ApprovedWithdrawnPhenolphthalein was withdrawn in Canada due to concerns with carcinogenicity in 1997.
Mixtures: Le 100 B, AGAROL M (EMULSION)Categories: Compounds used in a research, industrial, or household settingVecuronium
go.drugbank.com/drugs/DB01339ApprovedInvestigationalA non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. … Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or
Categories: P-glycoprotein substratesProducts: BROMURO DE VECURONIO 4 MG/VIAL POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLE, BROCURIX 10 MG POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCIÓN INYECTABLEPegfilgrastim
go.drugbank.com/drugs/DB00019ApprovedInvestigationalPegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, [filgrastim]. … [A29,A187607] Due to a longer half-life and slower elimination rate than filgrastim, pegfilgrastim requires less frequent dosing than filgrastim; however, pegfilgrastim has a comparable pharmacological
Categories: Compounds used in a research, industrial, or household settingSynonyms: 吉新芬, PEG-G-CSFConditions where a reduction of gastric acid secretion is required
go.drugbank.com/conditions/DBCOND0117234Drugs: PantoprazoleSynonyms: Conditions where a reduction of gastric acid secretion is requiredPleckstrin homology domain-containing family A member 4
go.drugbank.com/bio_entities/BE0001278TargetHumansBinds specifically to phosphatidylinositol 3-phosphate (PtdIns3P), but not to other phosphoinositides
Polypeptides: Pleckstrin homology domain-containing family A member 4Synonyms: PH domain-containing family A member 4Pleckstrin homology domain-containing family A member 1
go.drugbank.com/bio_entities/BE0003262TargetHumansBinds specifically to phosphatidylinositol 3,4-diphosphate (PtdIns3,4P2), but not to other phosphoinositides. May recruit other proteins to the plasma membrane
Polypeptides: Pleckstrin homology domain-containing family A member 1Synonyms: PH domain-containing family A member 1Potassium voltage-gated channel subfamily A member 4
go.drugbank.com/bio_entities/BE0004502TargetHumansLikewise, a heterotetrameric channel formed by KCNA1 and KCNA4 shows rapid inactivation (PubMed:17156368) … Homotetrameric KCNA4 forms a potassium channel that opens in response to membrane depolarization, followed by rapid spontaneous channel closure (PubMed:19912772, PubMed:8495559).
Polypeptides: Potassium voltage-gated channel subfamily A member 4A disintegrin and metalloproteinase with thrombospondin motifs 4
go.drugbank.com/bio_entities/BE0004687EnzymeTargetHumansCould be a critical factor in the exacerbation of neurodegeneration in Alzheimer disease … Cleaves aggrecan, a cartilage proteoglycan, at the '392-Glu-|-Ala-393' site and may be involved in its turnover (PubMed:10356395, PubMed:10827174). Also cleaves COMP (PubMed:39672391).
Polypeptides: A disintegrin and metalloproteinase with thrombospondin motifs 4